- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- MedicorPharma-Ural LLC
MedicorPharma-Ural LLC
MedicorPharma-Ural LLC has been a supplier of equipment for nuclear medicine and radioisotope products to healthcare institutions throughout Russia and abroad for more than 10 years.
Products supplied:
- radiopharmaceuticals based on I-131, Sm-153, Sr-89;
— technetium Тс-99m generators;
— microsources of radioactive emission based on I-125;
— intraoperative gamma-probe RadPointer;
— kits for the preparation of radiopharmaceuticals labeled with 99mTc;
— other products for nuclear medicine.
MedicorPharma-Ural LLC provides services for:
— support in customs clearance of radioisotope medical products for export and import operations;
— transportation of radioactive cargo (hazard class 7);
— development of projects for bringing goods and services to the Russian market;
— registration of the shipping packaging set;
— training in the use of medical devices and radiopharmaceuticals; – and others.
The company is a manufacturer of the RadPointer gamma- probe and 99mTc-labeled radiopharmaceutical preparation kits for high-tech patient care.
The RadPointer Intraoperative Gamma-Probe is designed to search for and localize sentinel lymph nodes during diagnostic and surgical procedures.
Sentiscan®, 99mTc is a kit for the preparation of a radiopharmaceutical labeled with 99mTc, which is a nanocolloidal aluminum solution.
It is used for scintigraphic imaging and intraoperative detection of sentinel lymph nodes in patients with various malignant neoplasms (including breast, melanoma of the skin, larynx and laryngopharynx, oral mucosa, vulva, cervix, endometrium, etc.).
Also, the line of kits for the preparation of diagnostic radiopharmaceuticals produced by MedicorPharma-Ural LLC includes drugs for the diagnosis of malignant tumors of the prostate, brain and neuroendocrine tumors.
Disinfectant (skin antiseptic) DEZITOL A
Skin antiseptic based on isopropyl alcohol for hand treatment, including hands of surgeons, operating field, injection field, gloves on the hands of medical personnel (in accordance with the instructions for use). Having high antimicrobial activity, it is gentle for skin. Effective against pathogens of healthcare-associated infections and Mycobacterium tuberculosis (tested on Mycobacterium terrae).
Passed tests at Disinfectology Research Institute of the Federal Service for the Oversight of Consumer Protection and Welfare.
Effective against pathogens of healthcare-associated infections and Mycobacterium tuberculosis (tested on Mycobacterium terrae).
It is intended for hygienic treatment of hands of personnel at industrial enterprises, catering facilities, municipal facilities, sanitary inspection checkpoints, hairdressing salons, beauty salons, etc.
MedicorPharma-Ural LLC has all the necessary licenses, including a license to operate radiation sources and to carry out pharmaceutical activities. It is also certified according to international operating standards ISO 9001:2015 (GOST R ISO 9001-2015 Quality management systems. Requirements), ISO 13485:2017 (GOST ISO 13485-2017 Medical devices. Quality management systems. Requirements for regulatory purposes).
28/1, Kirova St., Ekaterinburg
+7 (343) 270-75-29
8 800 600 33 90
